Jack W. Callicutt sold $1.61M worth of shares in Galectin Therapeutics, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.